Company intelligence / Profile preview

VIVEbiotech

San Sebastian / Donostia, Gipuzkoa/Basque Country, Spainvivebiotech.com ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

VIVEbiotech is a leading European CDMO specializing exclusively in GMP-compliant lentiviral vector development and manufacturing. The company serves over 40 biotech companies globally as a trusted partner in gene and cell therapy projects, supporting preclinical through commercial stages. Its proprietary LENTISOMA technology offers non-integrative episomal vectors with enhanced safety profiles. In December 2024, it secured growth investment from Ampersand Capital Partners to expand its San Sebastian facility and capabilities. The company has won industry awards such as CMO/CDMO of the Year at the Advanced Therapies Awards.

Therapeutic areas: OncologyRare Diseases
Modalities: Gene therapyLentiviral vector therapyCell therapy
Industry: Contract Manufacturing Organization

Partnerships

Over forty global biotech/pharma partners as clients

Beyond the preview

Go deeper on VIVEbiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIVEbiotech.

Explore the full profile